API
TAK icon

Advisor Partners II’s Takeda Pharmaceutical TAK Stock Holding History

Advisor Partners II’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.24M Buy
80,100
+12,802
+19% +$198K 0.05% 410
2023
Q2 		$1.06M Buy
67,298
+14,696
+28% +$241K 0.05% 373
2023
Q1 		$867K Buy
52,602
+15,163
+41% +$242K 0.05% 380
2022
Q4 		$584K Buy
37,439
+8,247
+28% +$115K 0.04% 478
2022
Q3 		$379K Buy
+29,192
New +$406K 0.03% 545

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Advisor Partners II's TAK Position: Q3 2023 in Review

Advisor Partners II increased its Takeda Pharmaceutical (TAK) stake by 19% in Q3 2023, buying an estimated $198K and bringing the position to 80,100 shares worth $1.24M. The position accounts for 0.05% of the portfolio, ranked #410.

Advisor Partners II first reported a position in TAK in Q3 2022 and has held it in 5 quarters since. 312 funds tracked by Wall St. Rank hold TAK as of Q3 2023.

  • Advisor Partners II held 80,100 shares of Takeda Pharmaceutical worth $1.24M as of Q3 2023.
  • Advisor Partners II bought 12,802 Takeda Pharmaceutical shares in Q3 2023, an estimated $198K.
  • Takeda Pharmaceutical made up 0.05% of Advisor Partners II's portfolio in Q3 2023, its #410 holding.
  • Advisor Partners II first reported a position in Takeda Pharmaceutical in Q3 2022 and has held it in 5 quarters since.
  • 312 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.